22. Moyamoya disease Clinical trials / Disease details


Clinical trials : 14 Drugs : 21 - (DrugBank : 14) / Drug target genes : 28 - Drug target pathways : 44

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR2100046178
2021-05-102021-05-08Efficacy and safety of antiplatelet drugs in patients with moyamoya disease after revascularization Efficacy and safety of antiplatelet drugs in patients with moyamoya disease after revascularization Moyamoya diseaseTaking aspirin group:Nil;No aspirin group:Nil;Qilu Hospital of Shandong UniversityNULLRecruiting060BothTaking aspirin group:105;No aspirin group:105;china
2NCT04012268
(ClinicalTrials.gov)
July 15, 20193/7/2019The Safety and Efficacy of RIC on Adult Moyamoya DiseaseThe Safety and Effect of Remote Ischemic Conditioning on Adult Moyamoya DiseaseMoyamoya DiseaseDevice: RIC;Drug: AspirinCapital Medical UniversityNULLCompleted18 Years60 YearsAll30N/AChina
3ChiCTR1800020377
2019-01-012018-12-27Aspirin in Moyamoya DiseaseThe Clinical Benefit and Risk of Oral Aspirin for Moyamoya Disease moyamoya diseaseCase series:Aspirin;Beijing Tiantan Hospital, Capital Medical UniversityNULLRecruiting860BothCase series:300;China